(In second sentence of paragraph 7, changes first word from "Three" to "Six": Six (35.3%) showed positive...) By Marilynn Larkin NEW YORK (Reuters Health) - An ongoing first-in-human trial suggests Read More »
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with advanced melanoma treated with pembrolizumab monotherapy, a radiomic signature derived from baseline computed tomography (CT) images may Read More »
By Brendan Pierson NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other Read More »
By Manojna Maddipatla and Leroy Leo (Reuters) - The Omicron variant appears to result in less severe COVID-19 than seen during previous periods of high coronavirus transmission including the Delta Read More »
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with resistant metastatic non-small-cell lung cancer (NSCLC), adding radiation to PD-L1 and CTLA-4 inhibition alone or combination did not Read More »
By Reuters Staff (Reuters Health) - Screening for human papillomavirus (HPV) in high-risk individuals may be done effectively and noninvasively using menstrual blood testing with target-capture Read More »
By Francesco Guarascio and Emma Farge BRUSSELS/GENEVA (Reuters) - U.S. financial contributions to the World Health Organization (WHO) has fallen by 25% during the coronavirus pandemic, provisional Read More »
By Reuters Staff WASHINGTON (Reuters) - A COVID-19 vaccine specifically targeting the Omicron variant would be "prudent" even if it ultimately may not be needed, the top U.S. infectious disease Read More »
